MetLife Investment Management
CDXS icon

MetLife Investment Management’s Codexis CDXS Stock Holding History

MetLife Investment Management’s Portfolio CDXS Stock Details CDXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Buy
+52,011
New +$129K ﹤0.01% 2709
2025
Q4 		– Sell
-35,281
Closed -$86.1K – 2822
2025
Q3 		$86.1K Sell
35,281
-15,068
-30% -$41.1K ﹤0.01% 2713
2025
Q2 		$123K Buy
50,349
+30,533
+154% +$71.6K ﹤0.01% 2438
2025
Q1 		$53.3K Sell
19,816
-26,344
-57% -$102K ﹤0.01% 2687
2024
Q4 		$220K Buy
46,160
+28,569
+162% +$118K ﹤0.01% 2258
2024
Q3 		$54.2K Sell
17,591
-21,604
-55% -$66.8K ﹤0.01% 2747
2024
Q2 		$122K Buy
39,195
+4,270
+12% +$13.7K ﹤0.01% 2505
2024
Q1 		$122K Buy
34,925
+550
+2% +$1.73K ﹤0.01% 2447
2023
Q4 		$105K Hold
34,375
– – ﹤0.01% 2591
2023
Q3 		$65K Hold
34,375
– – ﹤0.01% 2788
2023
Q2 		$96.3K Buy
34,375
+10,708
+45% +$34.6K ﹤0.01% 2704
2023
Q1 		$98K Sell
23,667
-9,296
-28% -$48.8K ﹤0.01% 2562
2022
Q4 		$154K Hold
32,963
– – ﹤0.01% 2403
2022
Q3 		$200K Hold
32,963
– – ﹤0.01% 2307
2022
Q2 		$345K Hold
32,963
– – ﹤0.01% 1926
2022
Q1 		$680K Buy
32,963
+11,784
+56% +$244K ﹤0.01% 1588
2021
Q4 		$662K Hold
21,179
– – 0.01% 1341
2021
Q3 		$493K Sell
21,179
-3,434
-14% -$81.3K ﹤0.01% 1532
2021
Q2 		$558K Hold
24,613
– – ﹤0.01% 1503
2021
Q1 		$563K Hold
24,613
– – 0.01% 1455
2020
Q4 		$537K Hold
24,613
– – 0.01% 1456
2020
Q3 		$289K Hold
24,613
– – ﹤0.01% 1648
2020
Q2 		$281K Hold
24,613
– – ﹤0.01% 1694
2020
Q1 		$275K Hold
24,613
– – ﹤0.01% 1519
2019
Q4 		$394K Hold
24,613
– – ﹤0.01% 1594
2019
Q3 		$338K Hold
24,613
– – ﹤0.01% 1631
2019
Q2 		$454K Sell
24,613
-39,776
-62% -$767K ﹤0.01% 1538
2019
Q1 		$1.32M Buy
64,389
+42,926
+200% +$834K ﹤0.01% 1498
2018
Q4 		$358K Hold
21,463
– – ﹤0.01% 1564
2018
Q3 		$368K Hold
21,463
– – ﹤0.01% 1730
2018
Q2 		$309K Hold
21,463
– – ﹤0.01% 1702
2018
Q1 		$236K Hold
21,463
– – ﹤0.01% 1801
2017
Q4 		$179K Buy
+21,463
New +$149K ﹤0.01% 1989

Other funds holding CDXS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MetLife Investment Management's CDXS Position: Q2 2026 in Review

MetLife Investment Management opened a new position in Codexis (CDXS) in Q2 2026: 52,011 shares worth $118K. The stake represents ﹤0.01% of the portfolio and ranks #2709 among its holdings. This is a return to the name: MetLife Investment Management previously reported a position in CDXS as recently as Q3 2025.

MetLife Investment Management first reported a position in CDXS in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.32M in Q1 2019. 148 funds tracked by Wall St. Rank hold CDXS as of Q2 2026.

  • MetLife Investment Management held 52,011 shares of Codexis worth $118K as of Q2 2026.
  • Codexis was a new MetLife Investment Management position in Q2 2026.
  • Codexis made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2709 holding.
  • MetLife Investment Management first reported a position in Codexis in Q4 2017 and has held it in 33 quarters since.
  • MetLife Investment Management's Codexis position peaked at $1.32M in Q1 2019.
  • 148 funds tracked by Wall St. Rank held Codexis as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.